Is this the outcome of Phase 3 trial, or the outcome of the final FDA approval? Thanks.
This is the outcome of the regulatory decision on approval.
There is a separate variable in the raw data called “Dev Status”.
Dev Status is our label. We treat development status launched and registered as successes or 1; discontinued, suspended, and no development reported as failures or 0; and phase ii clinical trial, phase iii clinical trial, and pre-registration as pipeline programs (i.e., still under development) which have no label.